(Total Views: 421)
Posted On: 03/09/2021 2:48:56 PM
Post# of 153937
Based on the below news, SRNE is up 13%
Sorrento has identified potential mAb cocktails currently undergoing studies that could be effective against the U.K, South Africa, and Japan/Brazil SARS-CoV-2 variants.Separately, Sorrento's intravenous STI-2020 (COVI-AMG) is currently in phase 2 studies for mild-to-moderate COVID-19 patients both in and out of the hospital.
And LL in a "Phase III Trial" was found to reduce critical deaths in <66 ages by 31.8%, p value 0.0319 and we are down 25% yesterday, 20% today?
The world is upside down.
FDA? EUA? Our investments? Our Share Price?
Sorrento has identified potential mAb cocktails currently undergoing studies that could be effective against the U.K, South Africa, and Japan/Brazil SARS-CoV-2 variants.Separately, Sorrento's intravenous STI-2020 (COVI-AMG) is currently in phase 2 studies for mild-to-moderate COVID-19 patients both in and out of the hospital.
And LL in a "Phase III Trial" was found to reduce critical deaths in <66 ages by 31.8%, p value 0.0319 and we are down 25% yesterday, 20% today?
The world is upside down.
FDA? EUA? Our investments? Our Share Price?
(3)
(0)
